Welcome to ASPIRIN Health Series Newsletters

ASPIRIN is pleased to launch a series of two newsletters; one, Pain Management, designed to help you fight pain associated with inflammation such as arthritis, joint and body pain as well as pain of headaches, and the other, Preventative Therapy, to help you reduce the risk of cardiovascular disease. Each newsletter will be filled with helpful, timely advice on how to improve your health, and how our brand can help.

Simply complete all of the form below, indicating which of the two newsletter series you would like to receive (you can select both if you wish) and click Submit. Newsletters will be sent out every three months.

If you have already signed up, you can change your information here.

First Name*:

Last Name*:

Age*:

Gender*:

Female Male

Province*:

Postal Code*:

(e.g.: A1B 2C3)

E-mail Address*:

Create a Password*:

Confirm Password*:

Please sign me up to receive*:

	Pain Management
	Preventative Therapy

I would be interested in receiving other relevant information on ASPIRIN.

Send my e-mail as*:

HTML

Plain Text

* Required Items

Which products do you currently use for pain relief?
	Advil** (Regular Strength, Extra Strength, Liqui-Gels)
	ASPIRIN Original Strength (325mg)
	ASPIRIN Extra Strength (500mg)
	Coated ASPIRIN (325mg)
	Coated ASPIRIN (500mg)
	Coated ASPIRIN Arthritis Pain Relief (650mg)
	ASPIRIN With Stomach Guard
	Tylenol** Regular Strength
	Tylenol** Extra Strength
	Tylenol** Arthritis Pain
	Tylenol** 8 Hour
	Motrin** (Regular Strength, Extra Strength, Super Extra Strength)
	Store Brand
	Other
	Do Not Use

Which products do you currently use for preventative therapy?
	Asaphen** (81mg Coated, Chewable)
	ASPIRIN Original Strength (325mg)
	Coated ASPIRIN Daily Low Dose (81mg)
	Entrophen**
	Store Brand
	Other
	Do Not Use
	** trademarks of their respective owner

By submitting your information, you agree that this data will be governed by our Privacy Statement.

Health Series Newsletters contain information approved for Canadian markets and will not be knowingly sent to subscribers outside of Canada.